However, compared to the NCD group, the activating receptors NKG2D and Granzyme B were statistically decreased in the Healthy-FMT group, and granzyme B was statistically decreased in the NASH-FMT group (Figure 5c). Here, GZMB is linked to metabolic dysfunction-associated steatohepatitis.